Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.1500
0.00 (0.00%)
Oct 27, 2025, 8:00 PM EDT
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $985.22 thousand as of October 29, 2025. Its market cap has decreased by -94.67% in one year.
Market Cap
985.22K
Enterprise Value
18.05M
Revenue
899.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.15
Market Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 985.22K, an increase of 289.52%. That is a compound annual growth rate of 9.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 985.22K | -89.98% |
| Dec 31, 2024 | 9.83M | -38.42% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | 108.70M | 44.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 655.03M |
| Glass House Brands | 559.28M |
| Northwest Biotherapeutics | 394.58M |
| Silence Therapeutics | 345.28M |
| CytoDyn | 313.10M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 302.09M |